Medicine and Dentistry
ACE Inhibitor
11%
Angiotensin Receptor Antagonist
11%
Arteriosclerosis Obliterans
11%
Asthma
11%
Atrial Fibrillation
35%
Biological Marker
13%
C Reactive Protein
13%
Cardiology
14%
Cardiovascular System
5%
Case-Control Study
11%
Chronic Obstructive Pulmonary Disease
23%
Cohort Analysis
46%
Comorbidity
27%
Congestive Heart Failure
100%
Coronary Artery Disease
14%
COVID-19
46%
Diseases
5%
Dyspnea
6%
Ejection Fraction
46%
Electronic Health Record
18%
Hazard Ratio
7%
Health Care
11%
Heart Failure with Preserved Ejection Fraction
24%
Heart Failure with Reduced Ejection Fraction
8%
Heart Muscle Ischemia
11%
Hospital Mortality
28%
Infection
14%
Kidney Injury
7%
Neutrophil
5%
Patient Characteristics
5%
Prevalence
11%
Primary Health Care
6%
Remote Sensing
12%
Revascularization
11%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Heart Failure
11%
Angiotensin Receptor Antagonist
11%
Atrial Fibrillation
35%
Beta Adrenergic Receptor Blocking Agent
23%
Case-Control Study
11%
Chronic Obstructive Lung Disease
46%
Cohort Study
46%
Comorbidity
27%
Congestive Heart Failure
63%
Coronary Artery Disease
11%
Dipeptidyl Carboxypeptidase Inhibitor
11%
Functional Status
11%
Hospital Mortality
11%
Infection
14%
Peripheral Occlusive Artery Disease
11%
Prevalence
11%
Randomized Controlled Trial
8%
Nursing and Health Professions
Area under the Curve
5%
Asthma
11%
Atrial Fibrillation
11%
Beta Adrenergic Receptor Blocking Agent
12%
Biological Marker
14%
C Reactive Protein
14%
Clinical Outcome
26%
Comorbidity
5%
Confidence Interval
14%
Congestive Heart Failure
35%
Diseases
17%
Electronic Health Record
5%
Functional Status
11%
Health Care
8%
Hospital Management
11%
Hospital Mortality
14%
Kidney Injury
7%
Meta Analysis
11%
Neutrophil Count
5%
Obstructive Lung Disease
23%
Quality of Life
11%
Remote Sensing
11%
Socialized Medicine
8%
Systematic Review
11%
University Hospital
11%